Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular Carcinoma
Augusto Villanueva(NYU Langone Health), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Myron Schwartz(Icahn School of Medicine at Mount Sinai), Daniela Sia(Icahn School of Medicine at Mount Sinai), Helena Cornellà(Universitat de Barcelona), Clara Alsinet(Hospital Clínic de Barcelona), Jian‐Bing Fan(Southern Medical University), Carlo Battiston, Victoria Tovar(Hospital Clínic de Barcelona), Arthur Liberzon(Broad Institute), Vincenzo Mazzaferro(Fondazione IRCCS Istituto Nazionale dei Tumori), Philippa Newell, Jordi Bruix(Hospital Clínic de Barcelona), Swan N. Thung(Icahn School of Medicine at Mount Sinai), Masahiro Kobayashi(Toranomon Hospital), Hiromitsu Kumada(Toranomon Hospital), Yujin Hoshida(Broad Institute), Sasan Roayaie(White Plains Hospital), Craig April(Illumina (United States))
Cited by 466
Related Papers
Management of Hepatocellular Carcinoma: An Update Δσ
|Hepatology|2011|8.1k
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
|New England Journal of Medicine|1996|7.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Management of Hepatocellular Carcinoma *
|Hepatology|2005|5.9k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k